SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling

Bolin Hou, Gang Wang, Quan Gao, Yanjie Wei, Caining Zhang, Yange Wang, Yuqing Huo, Huaiyi Yang, Xuejun Jiang, Zhijun Xi

Research output: Contribution to journalArticle

Abstract

Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma. It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial. Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored. In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner. In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62. An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62. Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.

Original languageEnglish (US)
Number of pages1
JournalScientific reports
Volume9
Issue number1
DOIs
StatePublished - Jul 31 2019

Fingerprint

AMP-Activated Protein Kinases
Autophagy
Acetyl-CoA Carboxylase
Receptor Protein-Tyrosine Kinases
sunitinib
Immunoprecipitation
Phosphorylation
Staining and Labeling
Carcinoma
Kidney
Cell Line

ASJC Scopus subject areas

  • General

Cite this

SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling. / Hou, Bolin; Wang, Gang; Gao, Quan; Wei, Yanjie; Zhang, Caining; Wang, Yange; Huo, Yuqing; Yang, Huaiyi; Jiang, Xuejun; Xi, Zhijun.

In: Scientific reports, Vol. 9, No. 1, 31.07.2019.

Research output: Contribution to journalArticle

Hou, Bolin ; Wang, Gang ; Gao, Quan ; Wei, Yanjie ; Zhang, Caining ; Wang, Yange ; Huo, Yuqing ; Yang, Huaiyi ; Jiang, Xuejun ; Xi, Zhijun. / SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling. In: Scientific reports. 2019 ; Vol. 9, No. 1.
@article{bc6dd4a7c68046f4a1e99803e5fbf1cb,
title = "SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling",
abstract = "Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma. It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial. Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored. In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner. In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62. An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62. Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.",
author = "Bolin Hou and Gang Wang and Quan Gao and Yanjie Wei and Caining Zhang and Yange Wang and Yuqing Huo and Huaiyi Yang and Xuejun Jiang and Zhijun Xi",
year = "2019",
month = "7",
day = "31",
doi = "10.1038/s41598-019-47597-4",
language = "English (US)",
volume = "9",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - SQSTM1/p62 loss reverses the inhibitory effect of sunitinib on autophagy independent of AMPK signaling

AU - Hou, Bolin

AU - Wang, Gang

AU - Gao, Quan

AU - Wei, Yanjie

AU - Zhang, Caining

AU - Wang, Yange

AU - Huo, Yuqing

AU - Yang, Huaiyi

AU - Jiang, Xuejun

AU - Xi, Zhijun

PY - 2019/7/31

Y1 - 2019/7/31

N2 - Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma. It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial. Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored. In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner. In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62. An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62. Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.

AB - Sunitinib (ST), a multitargeted receptor tyrosine kinase inhibitor, has been demonstrated to be effective for the treatment of renal carcinoma. It has been reported that ST is involved in the mediation of autophagy; however, its regulatory role in the autophagic process remains controversial. Furthermore, the mechanism by which activated AMP-activated protein kinase (AMPK) negatively regulates autophagy remains nearly unexplored. In the present study, we revealed that ST inhibited AMPK activity and regulated autophagy in a cell type- and dose-dependent manner. In a number of cell lines, ST was demonstrated to inhibit H2O2-induced autophagy and the phosphorylation of acetyl-CoA carboxylase (ACC), whereas alone it could block the autophagic flux concurrent with increased expression of p62. An immunoprecipitation assay revealed that LC3 directly interacted with p62, whereas ST increased punctate LC3 staining, which was well colocalized with p62. Taken together, we reveal a previously unnoticed pathway for ST to regulate the autophagic process, and p62, although often utilized as a substrate in autophagy, plays a critical role in regulating the inhibition of ST in both basal and induced autophagy.

UR - http://www.scopus.com/inward/record.url?scp=85070899415&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070899415&partnerID=8YFLogxK

U2 - 10.1038/s41598-019-47597-4

DO - 10.1038/s41598-019-47597-4

M3 - Article

C2 - 31366950

AN - SCOPUS:85070899415

VL - 9

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

ER -